Pentobarbital will minimize the extent or outcome of nitrendipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known. pentobarbital will reduce the level or outcome of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated (one)pentobarbital decreases amounts of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 ... https://normanh913bvl5.bloggactivo.com/profile